Proteomics market was valued at $21.12 billion in 2019, and is projected to reach $49.97 billion by 2027 at a CAGR of 12.2% from 2020 to 2027. Proteomics has the capacity to explain questions that were unsolved by genomics, as proteins are the functional unit of cells. Advancements in technologies such as mass spectrometry and chromatography and development of computer algorithms for database searching facilitate proteomics research. The analysis of target proteins for disease diagnosis is the largest application of proteomics.
List of Key Players
Download Sample Report: https://www.alliedmarketresearch.com/request-sample/1677
Key Findings Of The Study
- The reagents segment generated the highest revenue in 2019, and is projected to grow at a CAGR of 11.7% during the forecast period.
- The instruments segment is anticipated to grow at the highest CAGR throughout the forecast period.
- Drug discovery dominated the global proteomics applications market in 2019, accounting for nearly 60.0% of the share of the proteomics market size in 2019.
- In 2019, the U.S. was the leading country, occupying the largest proteomics market share in North America.
For Purchase inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/1677
By reagents segment, immunoassays held the highest proteomics market share in the total market, as they are extensively utilized in primary screening in drug discovery and microarray technologies. On the basis of application, the drug discovery segment accounted for the majority market share in 2019, owing to increase in awareness of personalized medicines in both emerging and developed markets, thereby boosting the proteomics market growth in coming years.
North America held the largest proteomics market share of nearly 39.0% of the total market in 2019, due to increase in popularity and adoption of personalized medicines and favorable government funding & initiatives to develop novel therapeutics. However, Asia-Pacific is expected to grow at a CAGR of 15.6% from 2019 to 2027, owing to rise in prevalence of chronic diseases and increase in interest of researchers to utilize proteomics in disease diagnosis & treatment.
The global proteomics market is segmented on the basis of component, application, and region. On the basis of component, the market is categorized into reagents, instruments, and services. The reagents segment is further classified into microarray, spectrometry, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation reagents. Likewise, the proteomics instruments segment is sub segmented into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. The spectrometry segment is subdivided into mass spectrometry and NMR spectrometry. Similarly, the chromatography segment is sub classified into HPLC systems, ion chromatography, affinity chromatography, and supercritical fluid chromatography. The applications covered in the study include drug discovery, disease diagnosis, and others. Region wise, the proteomics market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
David Correa 5933 NE Win Sivers Drive 205, Portland, OR 97220 United States USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1(855)550-5975 [email protected]